IPierian, spinout land $30 million, target Alzheimer's, orphan diseases

After using its stem cell technology to discover drugs, iPierian Inc. and its backers are hoping that splitting into two companies and infusing them with a collective $30 million will bring an Alzheimer’s disease therapy and autoimmune drug to market faster...